A medical worker prepares to dilute a vial of Pfizer-BioNTech vaccine at a coronavirus disease (COVID-19) vaccination center in Singapore March 8, 2021. REUTERS/Edgar Su/File Photo
The European Commission on Friday authorized Pfizer (PFE.N) and partner BioNTech SE’s COVID-19 vaccine for use in children as young as 12, paving the way for a broader roll-out in the bloc after similar clearances in the United States and Canada.
The decision comes after European Medicines Agency (EMA) backed the use of the vaccine in 12- to 15-year olds earlier in the day.
The agency’s endorsement came weeks…
Connect with us on our socials: